Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Masayuki Chosa
Large‐Scale, Prospective Observational Study of Regorafenib in Japanese Patients With Metastatic Colorectal Cancer in a Real‐World Clinical Setting
Oncologist
Cancer Research
Medicine
Oncology
Related publications
Real‐World Adherence in Patients With Metastatic Colorectal Cancer Treated With Trifluridine Plus Tipiracil or Regorafenib
Oncologist
Cancer Research
Medicine
Oncology
Angiogenesis Genotyping and Clinical Outcome During Regorafenib Treatment in Metastatic Colorectal Cancer Patients
Scientific Reports
Multidisciplinary
Real-World Treatment Patterns Among Patients With Colorectal Cancer Treated With Trifluridine/Tipiracil and Regorafenib
Clinical Colorectal Cancer
Oncology
Gastroenterology
Thyroid Dysfunction and Ultrasonography Features in Patients With Metastatic Colorectal Cancer Treated With Regorafenib: Preliminary Results From a Single Centre Prospective Cohort Study
Endocrine Abstracts
Factors Associated With Regorafenib Adherence With Metastatic Colorectal Cancer
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
Regorafenib Adjusted Dose for Chilean Patients With Chemoresistant Metastatic Colorectal Cancer: A Case Series
ecancermedicalscience
Cancer Research
Oncology
KDR Gene as a Predictive Biomarker of Response to Regorafenib in Patients With Metastatic Colorectal Cancer (mCRC)
Journal of Pharmacogenomics & Pharmacoproteomics
A Phase I Study of Intravenous Aflibercept With FOLFIRI in Japanese Patients With Previously Treated Metastatic Colorectal Cancer
Investigational New Drugs
Oncology
Pharmacology
Real‐world Treatment Patterns and Outcomes in Refractory Metastatic Colorectal Cancer
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
